Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 65 announcements

Share price: ₹833.80
Market cap: ₹16,389 Cr
Revenue (annual): ₹7,345 Cr
Net profit (annual): ₹674.8 Cr
P/E (TTM): 23.6×Sector 47.3×
Promoter holding: 69.87%+0.13% QoQ
FII holding: 4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 13 Debt & Borrowing 9 Regulatory Approval 8 Merger & Restructuring 8 Earnings Call 5 Business Update 5 Other Announcement 3 Financial Results 3 Results Update 2 Credit Rating 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

10 Jul 2026 16:53 IST BSE

Dividend

Alembic Pharmaceuticals Dividend

Alembic Pharmaceuticals fixed July 29, 2026, as the record date for dividend entitlement. Payments will commence on August 6, 2026, subject to shareholder approval.

Read the filing ↗